| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6903 |
| Human Intestinal Absorption | HIA+ | 0.7413 |
| Caco-2 Permeability | Caco2- | 0.7476 |
| P-glycoprotein Substrate | Non-substrate | 0.5306 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9533 |
| Non-inhibitor | 0.9220 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9414 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8615 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8213 |
| CYP450 2D6 Substrate | Non-substrate | 0.8714 |
| CYP450 3A4 Substrate | Non-substrate | 0.6596 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8313 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8993 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9532 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9256 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9227 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9876 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9710 |
| Non-inhibitor | 0.8664 |
| AMES Toxicity | Non AMES toxic | 0.9468 |
| Carcinogens | Non-carcinogens | 0.8642 |
| Fish Toxicity | High FHMT | 0.6212 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8395 |
| Honey Bee Toxicity | High HBT | 0.5275 |
| Biodegradation | Ready biodegradable | 0.9863 |
| Acute Oral Toxicity | III | 0.4938 |
| Carcinogenicity (Three-class) | Non-required | 0.7834 |